DRUG NAME: Vinorelbine - BC Cancer

Vinorelbine is a moderate vesicant and can produce extravasation injury (eg, considerable irritation, local tissue necrosis and/or thrombophlebitis).

  Name, Drug, Drug name, Vinorelbine

10 mg in 1 mL and 50 mg in 5 mL Injection …

20130620_Vinorelbine Ebewe_Datasheet_v4.0_clean Page 1 of 15 DATA SHEET VINORELBINE EBEWE 10 mg in 1 mL and 50 mg in 5 mL Injection Concentrate

  Injection, Concentrate, Vinorelbine, In 5 ml injection, In 5 ml injection concentrate

Protocol: Carboplatin/Gemcitabine

Department of Medical Oncology Chemotherapy Protocols 3rd Edition 3 Protocol: Carboplatin/Vinorelbine Indications: Advanced – Lung, Breast and Ovarian cancer

  Protocol, Carboplatin, Gemcitabine, Carboplatin gemcitabine, Vinorelbine

CONTENTSOFSUPPLEMENT9 - EDQM

Contents of Supplement 9.4 EUROPEAN PHARMACOPOEIA 9.4 Sucralfate (1796) Temozolomide (2780) Urofollitropin (0958) Urokinase (0695) Vinorelbine tartrate (2107) Water, purified (0008)

  Vinorelbine

VINORELBINE 10MG/ML CONCENTRATE FOR …

MHRA-UKPAR – Vinorelbine 10mg/ml concentrate for solution for infusion PL 33410/0041 -2 - VINORELBINE 10MG/ML CONCENTRATE …

  Vinorelbine

BC CANCER HAZARDOUS DRUG LIST

BC CANCER HAZARDOUS DRUG LIST (Refer to: Pharmacy Directive VI-80 Hazardous Drug List) The BC Cancer Hazardous Drug List (BC Cancer HD List) is comprised of:

Drugs To Be Infused Through A Central Line

Drugs To Be Infused Through A Central Line (PICC Line) The Infusion Nurses Society Standards of Practice (2006) state that drugs which have a pH less than 5 and

  Line, Central, Through, Be infused through a central line, Infused

Chemotherapy extravasation guideline - …

Chemotherapy extravasation guideline WOSCAN September 2009 page 3 Introduction Aims of this guideline > To provide evidence-based guidance or best practice in the absence of evidence, on all aspects of extravasation